(Q35226263)

7 August 2017

1 reference

title

Weekly topotecan in the management of ovarian cancer (English)

1 reference

7 August 2017

1 reference

Robert T Morris

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

90

1 reference

7 August 2017

issue

3 Pt 2

1 reference

7 August 2017

page(s)

S34-8

1 reference

Epithelial ovarian cancer

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

Optimal sequencing in the treatment of recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

A dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

Weekly topotecan in the management of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900470-0

7 January 2021

10.1016/S0090-8258(03)00470-0

Identifiers

DOI

1 reference

7 August 2017

1 reference